OVERVIEW

14th Annual Comprehensive Neurotoxin Course for Neurological Conditions is organized by Cleveland Clinic and will be held from Mar 14 - 15, 2026 at Renaissance Dallas Hotel, Dallas, Texas, United States of America.

Description:
With the ever-growing therapeutic indications for toxin treatment, increasing numbers of available toxins, and the potential dangers and pitfalls if toxin injections are performed sub-optimally, there is a clear need for a comprehensive training of toxin injection. The clear educational need is for a thorough and intensive training that incorporates balanced and comprehensive didactic lectures, the opportunity to ask questions on uncertain areas, patient demonstrations, and true assessment of understanding of concepts and readiness for injection.

This comprehensive course will provide the practicing clinician or clinician-in-training the necessary knowledge needed to competently utilize all types of botulinum toxins, including the use of EMG and ultrasound, all adult and pediatric neurological indications. The course also features toxin injection demonstrations on patients and the opportunity to interact with North American thought-leaders in dystonia and toxin injections with reputations for being exemplary educators.

Learning Objectives:

  • Describe the fundamental pharmacology of botulinum toxin therapies, their mechanisms of action, duration and onset, potential side effects, and clinical indications.
  • List the FDA-approved botulinum toxin products and summarize their clinical indications, efficacy, side effects, dosing and administration, and role in clinical practice.
  • Review the different therapeutic uses of botulinum toxins in neurological disorders, both FDA-approved indications and off-label uses.
  • Discuss the advantages and disadvantages of neurotoxin injections, including ultrasound-guided injections, and describe their best use in clinical practice.
  • Describe the evidence-based practices for neurotoxin use in the pediatric population, including indications and dosing considerations.
  • Demonstrate proper techniques for administering botulinum toxins including anatomic localization, target and muscle selection, use of ultrasound guidance, and injection techniques.
  • Summarize the proper and ethical process of consent, preauthorization, billing, and coding for botulinum toxin use.

KEY DATES

Event Start Date
14 Mar, 2026
Event Start Date
Event End Date
15 Mar, 2026
Event End Date
Credits

In support of improving patient care, this activity has been planned and implemented by Cleveland Clinic Center for Continuing Education and Dystonia Medical Research Foundation. Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

  • 12.75 AMA PRA Category 1 Credits™
  • TARGET AUDIENCE

    PhysicianResidentsNeurologistsFellows

    SPECIALITIES

    NeurologistsMedical Toxicology

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationRenaissance Dallas Hotel
    2222 N Stemmons Fwy

    RELATED CONFERENCES & LIVE WEBINARS

    Sep 26 - 27, 2026 | Orlando, Florida, USA

    Neurology
    10 AMA PRA Category 1 Credits™
    ...
    More actions

    Nov 19 - 20, 2026 | Barcelona, ...

    Clinical Pharmacology
    More actions
    ES€199

    Nov 14 - 15, 2026 | Lake Buena Vista, ...

    Neurology
    10 AMA PRA Category 1 Credits™
    ...
    More actions